Nevro Corp. is expected to pay $20 million to Boston Scientific Corp. after a Delaware jury found that the medical device company had infringed on two Boston Scientific patents related to the manufacturing of a spinal cord stimulation technology, the company said late Monday.

from MarketWatch.com - Top Stories https://ift.tt/3pSvzPY
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3pSvzPY
via IFTTT
Kommentare
Kommentar veröffentlichen